Clinical Trial Update: Study of Sivelestat Sodium in OPCABG [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sivelestat sodium in patients undergoing off-pump coronary artery bypass grafting is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sivelestat sodium (sivelestat sodium)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Coronary Heart Disease, Coronary Artery Disease | Phase 2 | Status: RECRUITING